Comparison
21q22 11q22 12 Microdeletion Syndrome C5192593 vs 16q24 1 Microdeletion Syndrome C4749464
Clinical comparison between 21q22 11q22 12 Microdeletion Syndrome and 16q24 1 Microdeletion Syndrome for differential diagnosis and treatment planning.
21q22 11q22 12 Microdeletion Syndrome C5192593
A rare genetic condition involving deletion of a specific region on chromosome 21. It may cause developmental delay, intellectual disability, and distinctive facial features. Management focuses on developmental support and medical monitoring.
16q24 1 Microdeletion Syndrome C4749464
A chromosomal disorder caused by deletion of genetic material from chromosome 16. Individuals may experience developmental delays and various medical concerns. Coordinated specialist care is recommended.
6 comparison axes
Onset
21q22 11q22 12 Microdeletion Syndrome C5192593
0-0
16q24 1 Microdeletion Syndrome C4749464
0-null
Onset patterns differ
Severity
21q22 11q22 12 Microdeletion Syndrome C5192593
severe
16q24 1 Microdeletion Syndrome C4749464
moderate
Different severity levels
Chronic
21q22 11q22 12 Microdeletion Syndrome C5192593
Chronic
16q24 1 Microdeletion Syndrome C4749464
Chronic
Differing course
Communicable
21q22 11q22 12 Microdeletion Syndrome C5192593
No
16q24 1 Microdeletion Syndrome C4749464
No
Different transmission
Body System
21q22 11q22 12 Microdeletion Syndrome C5192593
congenital
16q24 1 Microdeletion Syndrome C4749464
congenital
Same/different system
Category
21q22 11q22 12 Microdeletion Syndrome C5192593
rare-disease
16q24 1 Microdeletion Syndrome C4749464
genetic
Different category
Bottom line
21q22-11q22-12-microdeletion-syndrome-C5192593 and 16q24-1-microdeletion-syndrome-C4749464 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 21q22 11q22 12 Microdeletion Syndrome C5192593 | 16q24 1 Microdeletion Syndrome C4749464 | Discriminating power |
|---|---|---|---|
| Developmental delay | Reported possible delay and intellectual disability; severity not quantified. | Developmental delay is possible, but pattern and severity are not established here. | Low |
| Facial appearance | Distinctive facial features are mentioned, without a defined pattern. | No specific facial pattern is supplied. | Low |
| Other medical concerns | Additional organ findings are not established by the source. | Various medical concerns are possible, but none are specified. | Low |
When to favor each condition
Choose 21q22 11q22 12 Microdeletion Syndrome C5192593 when
A confirmed deletion involving 21q22.11-q22.12
The chromosomal interval, not symptoms alone, identifies this condition.
High
Developmental disability with reported facial differences
This may prompt testing, but it does not establish the diagnosis.
Low
Source classification of severe congenital disease
Use only as supplied context, not as proof of individual prognosis.
Low
Choose 16q24 1 Microdeletion Syndrome C4749464 when
A confirmed deletion at 16q24.1
Genetic localization distinguishes it from a chromosome 21 deletion.
High
Unspecified developmental and medical concerns
These findings are nonspecific and require chromosomal confirmation.
Low
Source classification of moderate severity
This classification should not replace individualized assessment.
Low
How key tests differ
| Test | 21q22 11q22 12 Microdeletion Syndrome C5192593 | 16q24 1 Microdeletion Syndrome C4749464 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | May detect loss at 21q22.11-q22.12. | May detect loss at 16q24.1. | The deleted locus distinguishes the conditions; clinical correlation is required. |
| Karyotype | May miss a small deletion. | May also miss a small deletion. | A normal karyotype does not exclude either microdeletion. |
| Developmental assessment | May document delay or disability. | May document delay. | Assessment supports care but cannot identify the chromosome involved. |
Prognosis comparison
21q22 11q22 12 Microdeletion Syndrome C5192593
- Outcome
- Long-term outcome is not established; source severity is severe.
- Factors
- Deletion extent, associated anomalies, and developmental support may influence course.
16q24 1 Microdeletion Syndrome C4749464
- Outcome
- Long-term outcome is not established; source severity is moderate.
- Factors
- Specific medical complications and access to coordinated care may influence course.
Time frame: Lifelong, although individual course is variable.
No reliable mortality or functional comparison is established from the supplied data.
Complications comparison
| Complication | Presentation |
|---|---|
| Learning or developmental difficulty | Possible, including intellectual disability. Possible, extent not established. Early developmental services may help; outcomes vary. |
| Associated congenital anomalies | Not specifically established here. Possible but unspecified. Organ-specific evaluation should follow clinical findings. |
| Recurrence in a family | Depends on parental testing, not established here. Depends on parental testing, not established here. Genetic counseling is appropriate for both. |
Patient education highlights
- HighDiagnosis
A symptom pattern cannot reliably separate these conditions; genetic results and specialist review are needed.
- HighCare
Management is supportive and individualized, with developmental monitoring and treatment of identified medical problems.
- MediumInheritance
Neither condition is communicable. Family recurrence risk requires parental genetic evaluation.